Balaji MS, Girish M. A study of utility of delta IgG as a prognostic marker in Guillain Barre Syndrome after IV immunoglobulin treatment. Int. J. of Health Sci. [Internet]. 2022 Jun. 23 [cited 2024 Nov. 17];6(S5):4274-87. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/9555